These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 18820124

  • 1. Renal impairment following aminoglycoside therapy in cystic fibrosis.
    Tai A.
    Thorax; 2008 Oct; 63(10):936; author reply 936-7. PubMed ID: 18820124
    [No Abstract] [Full Text] [Related]

  • 2. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Al-Aloul M, Miller H, Alapati S, Stockton PA, Ledson MJ, Walshaw MJ.
    Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
    [Abstract] [Full Text] [Related]

  • 3. Case-control study of acute renal failure in patients with cystic fibrosis in the UK.
    Smyth A, Lewis S, Bertenshaw C, Choonara I, McGaw J, Watson A.
    Thorax; 2008 Jun; 63(6):532-5. PubMed ID: 18245146
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis.
    Kovesi TA, Swartz R, MacDonald N.
    N Engl J Med; 1998 Jan 01; 338(1):65-6. PubMed ID: 9424574
    [No Abstract] [Full Text] [Related]

  • 6. Should we stop using intravenous gentamicin in patients with cystic fibrosis?
    Goss CH.
    Thorax; 2008 Jun 01; 63(6):479-80. PubMed ID: 18511632
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aminoglycoside ototoxicity susceptibility in cystic fibrosis.
    Mulrennan SA, Helm J, Thomas RB, Dodd M, Jones A, Webb K.
    Thorax; 2009 Mar 01; 64(3):271-2. PubMed ID: 19252031
    [No Abstract] [Full Text] [Related]

  • 9. Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients.
    O'Donnell EP, Scarsi KK, Scheetz MH, Postelnick MJ, Cullina J, Jain M.
    Int J Antimicrob Agents; 2010 Jul 01; 36(1):94-5. PubMed ID: 20382508
    [No Abstract] [Full Text] [Related]

  • 10. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage.
    Cabrera J, Arroyo V, Ballesta AM, Rimola A, Gual J, Elena M, Rodes J.
    Gastroenterology; 1982 Jan 01; 82(1):97-105. PubMed ID: 6171479
    [No Abstract] [Full Text] [Related]

  • 11. [Acute renal insufficiency and nephrotoxic substances].
    Martínez Vea A.
    Med Clin (Barc); 1987 Jan 24; 88(3):103-6. PubMed ID: 3821272
    [No Abstract] [Full Text] [Related]

  • 12. Ciprofloxacin-induced renal insufficiency in cystic fibrosis.
    Moffett BS, Rosenstein BJ, Mogayzel PJ.
    J Cyst Fibros; 2003 Sep 24; 2(3):152-4. PubMed ID: 15463865
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Which are the factors of toxic and pharmacological risk implicated in occurrence of acute renal failure during the perioperative period?].
    Cittanova ML.
    Ann Fr Anesth Reanim; 2005 Feb 24; 24(2):167-76. PubMed ID: 15737503
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Case ∣ Metabolic alkalosis in a patient with cystic fibrosis.
    Geara AS, Parikh A, Rekhtman Y, Rao MK.
    Kidney Int; 2012 Feb 24; 81(4):421-2. PubMed ID: 22289798
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.